Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Spahn

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2026
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, et al.
World Journal of Urology|March 13, 2021
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancerDavid D'Andrea, Francesco Soria, Anne J Grotenhuis, et al.
Nature Communications|December 3, 2021
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progressionMarco Bolis, Daniela Bossi, Arianna Vallerga, et al.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
Nature Communications|February 19, 2021
Patient-derived xenografts and organoids model therapy response in prostate cancerSofia Karkampouna, Federico La Manna, Andrej Benjak, et al.
Frontiers in Surgery|December 27, 2016
Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node DissectionLisa Moris, Thomas Van den Broeck, Lorenzo Tosco, et al.
Urologic Oncology|November 14, 2017
Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)Derya Tilki, Thenappan Chandrasekar, Umberto Capitanio, et al.
Nature Communications|November 4, 2020
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticityJoanna Cyrta, Anke Augspach, Maria Rosaria De Filippo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 4, 2019
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinomaJavier González, Jeffrey J Gaynor, Juan I Martínez-Salamanca, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2026
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, et al.
World Journal of Urology|March 13, 2021
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancerDavid D'Andrea, Francesco Soria, Anne J Grotenhuis, et al.
Nature Communications|December 3, 2021
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progressionMarco Bolis, Daniela Bossi, Arianna Vallerga, et al.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
Nature Communications|February 19, 2021
Patient-derived xenografts and organoids model therapy response in prostate cancerSofia Karkampouna, Federico La Manna, Andrej Benjak, et al.
Frontiers in Surgery|December 27, 2016
Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node DissectionLisa Moris, Thomas Van den Broeck, Lorenzo Tosco, et al.
Urologic Oncology|November 14, 2017
Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)Derya Tilki, Thenappan Chandrasekar, Umberto Capitanio, et al.
Nature Communications|November 4, 2020
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticityJoanna Cyrta, Anke Augspach, Maria Rosaria De Filippo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 4, 2019
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinomaJavier González, Jeffrey J Gaynor, Juan I Martínez-Salamanca, et al.
Pageof 11